Displaying 1 to 20 of 21 investments
Company | Country | Date | Notes | ||
---|---|---|---|---|---|
51hejia.com |
26 Jul 2007 | Series B Initial investment. Round participant. Active |
|||
Argos Therapeutics Inc |
United States | 1 Apr 2008 | Series C |
||
Beijing Gaosi Bole Education Technology Co Ltd |
China | 1 Oct 2011 | Series A Active |
||
Biovex Inc Biotechnology company developing new generation biologics for the treatment of cancer and infectious disease. |
United States | N/A Active |
|||
Chimerix Inc |
United States | 1 Feb 2011 | Series F |
||
Cylene Pharmaceuticals Inc Clinical stage private company developing small molecule drugs against newly validated cancer targets. |
United States | 1 May 2005 | Series B Active |
||
Cylene Pharmaceuticals Inc Clinical stage private company developing small molecule drugs against newly validated cancer targets. |
United States | 1 Sep 2010 | Series D Active |
||
Green Biologics Ltd |
United Kingdom | 31 Jul 2013 | Venture Active |
||
Green Biologics Ltd |
United Kingdom | 16 May 2012 | Venture Active |
||
Green Biologics Ltd |
United Kingdom | 30 Jul 2010 | Series B Active |
||
Green Biologics Ltd |
United Kingdom | 4 Feb 2009 | Venture Active |
||
Inimex Pharmaceuticals Inc |
Canada | 1 Jun 2008 | Series B |
||
Liquidia Technologies Inc |
United States | 1 Jul 2010 | Series C |
||
Plastic Logic Ltd Manufacturer of plastic electronic displays |
United Kingdom | 1 Aug 2008 | Series E Initial investment. Round participant. Active |
||
Plastic Logic Ltd Manufacturer of plastic electronic displays |
United Kingdom | 1 Nov 2005 | Series C Active |
||
Serica Technologies Inc Medical device company pioneering silk-based biomaterial platforms for tissue rejuvenation. |
United States | N/A |
|||
ThingMagic Inc Radio frequency identification (RFID) technology company. |
United States | 1 Feb 2006 | Series A |
||
Traversa Therapeutics |
United States | 1 Feb 2008 | Series A Active |
||
Traversa Therapeutics |
United States | 1 Apr 2009 | Series B Active |
||
ViOptix Inc Develops, manufactures and markets innovative proprietary products for tissue oximetry, measuring oxygen saturation levels in tissues. |
United States | 1 Oct 2004 | Series C |